Skip to main content
Premium Trial:

Request an Annual Quote

Thirteen-Member Proteomics Innovation Network Debuts This Week

Premium

Thirteen proteomics service and product providers have formed a new organization this week that aims to provide "sample to discovery" solutions for all stages of proteomics research, and to address "critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling, and selective reaction monitoring," it said in a statement.

The group, called Proteomics Innovation Network, comprises: ProFACT Proteomics, Norton Scientific, Eprogen, Neolomed Biosciences, Focus Proteomics, New England Peptide, Ontario Cancer Biomarker Network, Innova Proteomics, Dualsystems Biotech, NewLibertyProteomics, Horluce BioConsulting, the Australian Proteome Analysis Facility, and Covaris.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.